The information highlighted (if any) are the most recent updates for this brand.
Vericiguat (Verquvo) is contraindicated in patients with concomitant use of other soluble guanylate cyclase (sGC) stimulators, such as riociguat [see Other Soluble Guanylate Cyclase Stimulators under Interactions].